Effects of Rivastigmine on Tremor and Other Motor Symptoms in Patients with Parkinson's Disease Dementia: A Retrospective Analysis of a Double-Blind Trial and an Open-Label Extension

Author： Oertel Wolfgang  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.31, Iss.1, 2008-01, pp. : 79-94

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Rivastigmine in Frontotemporal Dementia: An Open-Label Study

By Rita Moretti  

Drugs & Aging, Vol. 21, Iss. 14, 2004-01 ,pp. : 931-937

Adis International

Access to resources Recommend Favorite

Effects of melatonin on physical fatigue and other symptoms in patients with advanced cancer receiving palliative care: A double-blind placebo-controlled crossover trial

By Lund Rasmussen Charlotte   Klee Olsen Marc   Thit Johnsen Anna   Aagaard Petersen Morten   Lindholm Helena   Andersen Line   Villadsen Birgit   Groenvold Mogens   Pedersen Lise  

Cancer, Vol. 121, Iss. 20, 2015-10 ,pp. : 3727-3736

Blackwell Publishing

Access to resources Recommend Favorite

Economic Evaluation of Rivastigmine in Patients with Parkinson's Disease Dementia

By Willan Andrew R.  

PharmacoEconomics, Vol. 24, Iss. 1, 2006-01 ,pp. : 93-106

Adis International

Access to resources Recommend Favorite

Long-Term Effects of Rivastigmine Treatment on the Need for Psychotropic Medications in Nursing Home Patients with Alzheimer’s Disease: Results of a 52-Week Open-Label Study

By Edwards Keith  

Clinical Drug Investigation, Vol. 25, Iss. 8, 2005-01 ,pp. : 507-515

Adis International

Access to resources Recommend Favorite

Rivastigmine in Parkinson's disease dementia

By Chitnis Shilpa   Rao Jayaraman  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 8, 2009-08 ,pp. : 941-955

Informa Healthcare

Access to resources Recommend Favorite